stockrowProtagonist Therapeutics, Inc. (PTGX) vs Twist Bioscience Corporation (TWST)
- Protagonist Therapeutics, Inc. PTGX 132.53 −2.02%
- Twist Bioscience Corporation TWST 120.85 +0.20%
Protagonist Therapeutics, Inc. and Twist Bioscience Corporation are both Biotechnology companies. Protagonist Therapeutics, Inc. is the larger, with a market value of $8.8B against $7.9B — 1.1× the size. Twist Bioscience Corporation has negative trailing earnings, so its P/E is not meaningful; Protagonist Therapeutics, Inc. trades at 111×. Protagonist Therapeutics, Inc. grew revenue faster over the last twelve months: 34.8% against 19.2%. Protagonist Therapeutics, Inc. has the higher net margin (29.4% vs −31.7%) and the higher return on invested capital (61.8% vs −30.8%). Across the 18 metrics below, Protagonist Therapeutics, Inc. leads on 13 and Twist Bioscience Corporation on 5.
Valuation
Profitability
| Metric | PTGX | TWST | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 51.97% | 65.16% |
| Operating margin | 20.69% | (33.58%) | 0.00% |
| Net margin | 29.40% | (31.66%) | 0.00% |
| Free cash flow margin | 46.31% | (22.15%) | 0.00% |
| Return on equity | 10.98% | (29.59%) | (50.12%) |
| Return on assets | 10.34% | (20.78%) | (45.60%) |
| Return on invested capital | 61.84% | (30.83%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack